IBI110
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IBI110, covering 2023-10-12 to 2025-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC [Phase 1, Phase 2]